2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow PRX302: new trials by email Literature Review of PRX302 trials Research Report on PRX302
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) PRX302, Placebo - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Sophiris Bio Corp | 40 | 2011-09-01 | 2013-08-21 |
| PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer PSA-Activated PSA-PAH1 - Prostate Cancer | Phase 1 | Completed | Sophiris Bio Corp | 24 | 2006-03-01 | 2018-10-29 |
Lower Urinary Tract Symptoms (1) · Prostatic Hyperplasia (1) · Prostatic Neoplasms (1)
United States (2)
King S Coffield, M.D. (1) · Richard C. Yocum, MD (1)